Search research articles
Contact Us
Filters
Showing results (761-770 of 785) with videos related to
Page
of 79
Sort By:
Journal of Microscopy
|
April 23, 2026
Making the invisible visible: A global examination of careers and recognition for Imaging Scientists in core facilities
Kerry Thompson, Johanna Bischof, Yara Reis, et al.
Haematologica
|
August 28, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Parasites & Vectors
|
February 20, 2019
Correction to: Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe
Chiara Trevisan, Smaragda Sotiraki, Minerva Laranjo-González, et al.
Parasites & Vectors
|
November 1, 2018
Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe
Chiara Trevisan, Smaragda Sotiraki, Minerva Laranjo-González, et al.
Science Advances
|
October 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Atish Mohanty, Arin Nam, Saumya Srivastava, et al.
NPJ Digital Medicine
|
May 21, 2026
Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial
Borja García-Lorenzo, Ania Gorostiza, Nerea González, et al.
International Journal of Environmental Research and Public Health
|
February 25, 2023
Assessment of the Effectiveness, Socio-Economic Impact and Implementation of a Digital Solution for Patients with Advanced Chronic Diseases: The ADLIFE Study Protocol
Borja García-Lorenzo, Ania Gorostiza, Nerea González, et al.
Royal Society Open Science
|
January 4, 2021
ACE inhibition and cardiometabolic risk factors, lung <i>ACE2</i> and <i>TMPRSS2</i> gene expression, and plasma ACE2 levels: a Mendelian randomization study
Dipender Gill, Marios Arvanitis, Paul Carter, et al.
Journal of Medicinal Chemistry
|
June 26, 2009
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists
Richard A Hartz, Vijay T Ahuja, Argyrios G Arvanitis, et al.
Page
of 79
Search research articles
Search
Showing results (761-770 of 785) with videos related to
Sort By:
Page
of 79
Journal of Microscopy
|
April 23, 2026
Making the invisible visible: A global examination of careers and recognition for Imaging Scientists in core facilities
Kerry Thompson, Johanna Bischof, Yara Reis, et al.
Haematologica
|
August 28, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Parasites & Vectors
|
February 20, 2019
Correction to: Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe
Chiara Trevisan, Smaragda Sotiraki, Minerva Laranjo-González, et al.
Parasites & Vectors
|
November 1, 2018
Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: eastern Europe
Chiara Trevisan, Smaragda Sotiraki, Minerva Laranjo-González, et al.
Science Advances
|
October 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Atish Mohanty, Arin Nam, Saumya Srivastava, et al.
NPJ Digital Medicine
|
May 21, 2026
Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial
Borja García-Lorenzo, Ania Gorostiza, Nerea González, et al.
International Journal of Environmental Research and Public Health
|
February 25, 2023
Assessment of the Effectiveness, Socio-Economic Impact and Implementation of a Digital Solution for Patients with Advanced Chronic Diseases: The ADLIFE Study Protocol
Borja García-Lorenzo, Ania Gorostiza, Nerea González, et al.
Royal Society Open Science
|
January 4, 2021
ACE inhibition and cardiometabolic risk factors, lung <i>ACE2</i> and <i>TMPRSS2</i> gene expression, and plasma ACE2 levels: a Mendelian randomization study
Dipender Gill, Marios Arvanitis, Paul Carter, et al.
Journal of Medicinal Chemistry
|
June 26, 2009
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists
Richard A Hartz, Vijay T Ahuja, Argyrios G Arvanitis, et al.
Page
of 79